Seres Therapeutics, Inc. (MCRB)

15.96 +0.78 (+5.14%) USD  |  NASDAQ  |  Jan 16, 16:00
15.96 0.00 (0.00%) Pre-Market: 20:00
More

Seres Therapeutics Long Term Deferred Assets (Quarterly)

Long Term Deferred Assets (Quarterly) Chart

View Long Term Deferred Assets (Quarterly) for MCRB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Long Term Deferred Assets (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Long Term Deferred Assets (Quarterly) Range, Past 5 Years

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Long Term Deferred Assets (Quarterly) Benchmarks

View Long Term Deferred Assets (Quarterly) Benchmarks
Start Trial
Altimmune, Inc. --
NovaBay Pharmaceuticals, Inc. --
Palatin Technologies, Inc. --
Theriva Biologics, Inc. --
Oragenics, Inc. --